Citation: S. Liras et al., Ring closing metathesis mediated synthesis of 4a-aryloxodecahydroisoquinolines, intermediates in the preparation of novel opiates, ORG LETT, 3(22), 2001, pp. 3483-3486
Authors:
Chenard, BL
Welch, WM
Blake, JF
Butler, TW
Reinhold, A
Ewing, FE
Menniti, FS
Pagnozzi, MJ
Citation: Bl. Chenard et al., Quinazolin-4-one alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists: Structure-activity relationship of the C-2 side chain tether, J MED CHEM, 44(11), 2001, pp. 1710-1717
Authors:
Allen, MP
Blake, JF
Bryce, DK
Haggan, ME
Liras, S
McLean, S
Segelstein, BE
Citation: Mp. Allen et al., Design, synthesis and biological evaluation of 3-amino-3-phenylpropionamide derivatives as novel mu opioid receptor ligands, BIOORG MED, 10(6), 2000, pp. 523-526
Authors:
Robinson, RP
Laird, ER
Blake, JF
Bordner, J
Donahue, KM
Lopresti-Morrow, LL
Mitchell, PG
Reese, MR
Reeves, LM
Stam, EJ
Yocum, SA
Citation: Rp. Robinson et al., Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffold, J MED CHEM, 43(12), 2000, pp. 2293-2296
Authors:
Reiter, LA
Rizzi, JP
Pandit, J
Lasut, MJ
McGahee, SM
Parikh, VD
Blake, JF
Danley, DE
Laird, ER
Lopez-Anaya, A
Lopresti-Morrow, LL
Mansour, MN
Martinelli, GJ
Mitchell, PG
Owens, BS
Pauly, TA
Reeves, LM
Schulte, GK
Yocum, SA
Citation: La. Reiter et al., Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S-2 pocket, BIOORG MED, 9(2), 1999, pp. 127-132
Authors:
Kim, Y
Oksanen, DA
Massefski, W
Blake, JF
Duffy, EM
Chrunyk, B
Citation: Y. Kim et al., Inclusion complexation of ziprasidone mesylate with beta-cyclodextrin sulfobutyl ether, J PHARM SCI, 87(12), 1998, pp. 1560-1567